Title
Category
Credits
Event date
Cost
Advanced Education Certification Series: Cannabinoids
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00
Advanced Education Certification Series: Opioids
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00
Advanced Education Certification Series: Palliative Care
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00
A Shifting Paradigm: Translating Research into Treatment Approaches for ALS
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
$0.00
Many providers lack knowledge regarding amyotrophic lateral sclerosis (ALS) and may be unaware of available information. Arming providers with an expansive understanding is extremely important. This activity highlights the need for education efforts to provide healthcare providers with clinical updates and tools to ensure that their patients receive the best possible care.
Clinical Spotlight: Pediatric Diagnosis & Treatment for Rett Syndrome
  • TME
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
Rett Syndrome is one of the most frequent causes of mental disability in females, with an estimated prevalence of 1 in 10,000 under the age of 12. It is characterized by normal early growth and development followed by a slowing of development, loss of purposeful use of the hands, distinctive hand movements, slowed brain and head growth, problems with walking, seizures, and intellectual disability.
Overwhelmed and Underdiagnosed: Understanding ADHD in Female Patients
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
$0.00
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in females. The presence of comorbid psychiatric disorders, including depression and anxiety, and obsessive compulsive disorder, may mitigate symptoms and delay diagnosis. The short-term effects of undiagnosed or undertreated ADHD in females presents a range of academic and social problems during childhood and adolescence. This course will provide participants an overview of current diagnostic practices and emerging treatment for ADHD in females.
Hunting for Better Outcomes: Management Options for Huntington’s Disease
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
$0.00
Huntington’s disease (HD) is a rare, progressive, genetic disorder resulting in a breakdown of nerve cells in the brain. Many types of clinicians are involved in the patient journey because HD affects movement, behavior, memory loss, impulse control, and the ability to do the simplest self-care activities. This multimedia activity provides the collaborative care team of neurologists, psychiatrists, and allied healthcare providers with an improved understanding of the fundamentals of HD, its chronic burden, and how to treat patients accordingly. Hunting for Better Outcomes provides HCPs with an enhanced understanding of HD and tools for improving overall patient outcomes.
Webcast: Screening, Diagnosis and Treatment of IDA in NDD-CKD
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
$0.00
Iron deficiency anemia (IDA) is a common condition in patients with non–dialysis-dependent chronic kidney disease (NDD-CKD) that can affect quality of life and lead to suboptimal outcomes. Despite the impacts of IDA in NDD-CKD patients, its screening, diagnosis, and treatment remains challenging. Recent trials and evidence has shown that i.v. iron supplementation for the treatment of IDA might be beneficial in this setting, and during this webcast,, experts will discuss important advances and considerations about the screening, diagnosis, and treatment of IDA in patients with NDD-CKD.
Webcast: Challenging Cases in NDD-CKD patients with IDA
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
$0.00
Iron deficiency anemia (IDA) is the most common cause of anemia in patients with non–dialysis-dependent chronic kidney disease (NDD-CKD) and addressing this condition is important in the overall management of these patients. During this webcast, expert faculty utilize challenging cases to discuss important clinical pearls about the screening, diagnosis and treatment of IDA in NDD-CKD.This activity is part of the IDA in NDD-CKD Digital Education Hub.
A Closer Look: CDKL5 Deficiency Disorder & Rescue Treatment
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
$0.00
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a rare developmental epileptic encephalopathy caused by mutations in the CDLK5 gene. The CDKL5 gene provides instructions for making proteins essential for normal brain and neuron development. When there is a deficiency disorder, a hallmark symptom is seizures beginning at approximately 3 months of life.

Pages